Ocular penetration of oral doxycycline in the horse

Veterinary Ophthalmology

Volumn 8, Issue 5, 2005, Pages 331-335

  Gilmour, Margi A ^a   Clarke, Cyril R ^a   MacAllister, Charles G ^a   Dedeo, Jacqueline M ^a   Caudell, David L ^a   Morton, Rebecca J ^a   Pugh, Martin ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Doxycycline; Equine; Equine recurrent uveitis; Eye; Leptospira

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ANIMAL; ANIMAL DISEASE; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CHEMISTRY; FEMALE; HORSE; HORSE DISEASE; METABOLISM; ORAL DRUG ADMINISTRATION; UVEITIS; VITREOUS BODY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DOXYCYCLINE; FEMALE; HORSE DISEASES; HORSES; UVEITIS; VITREOUS BODY;

EQUIDAE; EQUUS CABALLUS; LEPTOSPIRA;

EID: 26244437007     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2005.00422.x     Document Type: Article

References (35)

1. Sharp WN. Ophthalmology for Veterinarians. W.B. Saunders, Philadelphia, 1913.
2. Dwyer AE, Crockett RS, Kalsow CM. Association of leptospiral seroreactivity and breed with uveitis and blindness in horses: 372 cases (1986-1993). Journal of the American Veterinary Medical Association 1995;207:1327-1331.
3. Williams RD, Morter RL, Freeman MJ et al. Experimental chronic uveitis - ophthalmic signs following equine leptospirosis. Investigative Ophthalmology 1971; 10: 948-954.
4. Brooks DE. Equine ophthalmology. In: Veterinary Ophthalmology, 3rd edn. (ed. Gelatt KN) Lippincott Williams & Wilkins, Baltimore, MD, 1999; 1053-1116.
5. Rathinam SR, Rathnam S, Selvaraj S et al. Uveitis associated with an epidemic outbreak of leptospirosis. American Journal of Ophthalmology 1997; 124: 71-79.
6. Wollanke B, Rohrbach BW, Gerhards H. Serum and vitreous humor antibody titers in and isolation of Leptospira interrogans from horses with recurrent uveitis. Journal of the American Veterinary Medical Association 2001; 219: 795-800.
7. Faber NA, Crawford M, LeFebvre RB et al. Detection of Leptospira spp. in the aqueous humor of horses with naturally acquired recurrent uveitis. Journal of Clinical Microbiology 2000; 38: 2731-2733.
8. Frühauf B, Ohnesorge B, Deegen E et al. Surgical management of equine recurrent uveitis with single port pars plana vitrectomy. Veterinary Ophthalmology 1998; 1: 137-151.
9. Kalsow CM, Turpin LC, Dwyer AE. Immunopathology of eyes and pineal glands in equine recurrent uveitis. Regional Immunology 1994; 6: 15-19.
10. Kalsow CM, Dwyer AE. Retinal immunopathology in horses with uveitis. Ocular Immunology and Inflammation 1998; 6: 239-251.
11. Lucchesi PM, Parma AE. A DNA fragment of Leptospira interrogans encodes a protein which shares epitopes with equine cornea. Veterinary Immunology and Immunopathology 1999; 71: 173-179.
12. Greene CE, Shotts EB. Leptospirosis. In: Infectious Diseases of the Dog and Cat. (ed. Greene CE) W.B. Saunders, Philadelphia, 1990; 498-505.
13. Davidson MG, Nasisse MP, Roberts SM. Immunodiagnosis of leptospiral uveitis in two horses. Equine Veterinary Journal 1987; 19: 155-157.
14. Sillerud CL, Bey RF, Ball M et al. Serologic correlation of suspected Leptospira interrogans serovar pomona-induced uveitis in a group of horses. Journal of the American Veterinary Medical Association 1987; 191: 1576-1578.
15. Matthews AG. Serological study of leptospiral infections and endogenous uveitis among horses and ponies in the United Kingdom. Equine Veterinary Journal 1987; 19: 125-128.
16. Bernard WV. Leptospirosis. Veterinary Clinics of North America: Equine Practice 1993; 9: 435-444.
17. Thiermann AB. Leptospirosis: current developments and trends. Journal of the American Veterinary Medical Association 1984; 184: 722-725.
18. Shalit I, Barnea A, Shahar A. Efficacy of ciprofloxacin against Leptospira interrogans serogroup icterohaemorrhagiae. Antimicrobial Agents and Chemotherapy 1989; 33: 788-789.
19. Riviere JE, Spoo JW. Tetracycline antibiotics. In: Veterinary Pharmacology and Therapeutics, 7th edn. (ed. Adams RH) Iowa State University Press, Ames, Iowa, 1995; 784-796.
20. Bryant JE, Brown MP, Gronwall RR et al. Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations. Equine Veterinary Journal 2000; 32: 233-238.
21. Riond JL, Riviere JE, Duckett WM et al. Cardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses and ponies. Equine Veterinary Journal 1992; 24: 41-45.
22. Clarke CR, Wang Z, Cudd L et al. Pharmacokinetics of two long-acting oxytetracycline products administered subcutaneously and intramuscularly. Journal of Veterinary Pharmacology and Therapeutics 1999; 22: 65-67.
23. Bourne DWA. BOOMER, a simulation and modeling program for pharmacokinetic and pharmacodynamic data analysis. Computer Methods and Programs in Biomedicine 1989; 29: 191-195.
24. Cooley PL, Milvae R, Riis RC et al. Effect of flunixin meglumine on prostacyclin accumulation in the equine eye. American Journal of Veterinary Research 1984; 45: 1383-1385.
25. Regnier A, Whitley RD, Benard P et al. Effect of flunixin meglumine on the breakdown of the blood-aqueous barrier following paracentesis in the canine eye. Journal of Ocular Pharmacology 1986; 2: 165-170.
26. Regnier AM, Dossin O, Cutzach EE et al. Comparative effects of two formulations of indomethacin eyedrops on the paracentesis-induced inflammatory response of the canine eye. Veterinary and Comparative Ophthalmology 1995; 5: 242-246.
27. Barza M. Anatomical barriers for antimicrobial agents. European Journal of Clinical Microbiology and Infectious Disease 1993; 12 (Suppl. 1):S31-S35.
28. Barza M, Brown RB, Shanks C et al. Relation between lipophilicity and pharmacologic behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrobial Agents and Chemotherapy 1975; 8: 713-720.
29. Salminen L. Penetration of ocular compartments by tetracyclines II. An experimental study with doxycycline. Graefes Archiv für Klinische und Experimentelle Ophthalmologie 1977; 204: 201-207.
30. Kahán IL, Pápai I, Hammer H. Intraocular penetration of tritetracyclines after parenteral and subconjunctival administration. Albrecht v. Graefes Archiv für Klinische und Experimentelle Ophthalmologie 1974; 190: 257-265.
31. Whelan NC, Richardson RJ, Kinyon JM. Ocular and serum pharmacokinetics of intravenous doxycycline in the dog (Abstract). 31st Annual Meeting of the American College of Veterinary Ophthalmologists 2000; 35.
32. Latimer FG, Colitz CMH, Campbell NB et al. Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses. American Journal of Veterinary Research 2001; 62: 1606-1611.
33. Goldblum D, Rohrer K, Frueh BE et al. Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model. Antimicrobial Agents and Chemotherapy 2002; 46: 3719-3723.
34. Hospenthal DR, Murray CK. In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrobial Agents and Chemotherapy 2003; 47: 2646-2648.
35. Aronson AL. Pharmacotherapeutics of the newer tetracyclines. Journal of the American Veterinary Medical Association 1980; 176: 1061-1068.